Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Lens barrel and imaging device
Distylium plant named `PIIDIST-II`
Low powered activation arrangement and method thereof
Active and progressive targeted advertising
Establishing a graphical user interface (`GUI`) theme
Configurations and methods for effluent gas treatment
  Randomly Featured Patents
Cosmetic or dermatological light-protective formulation comprising a water-soluble UV filter substance and a benzoxazole derivative
Digitally controlled clamshell press
Raised source and drain IGFET device and method
Spray head for showers
Optical sheet, backlight assembly and display device having the same
Fluidtight seal for a container
Overmolded flowthrough turbidity sensor
Sewing machine with a drive mechanism for a fabric holder, E.G., an embroidery frame
Extraction of precious metals from ores thereof
Water soluble ammonium siloxane compositions and their use as fiber treatment agents